Phenobarbital-induced gingival hyperplasia

Journal of Contemporary Dental Practice

Volumn 8, Issue 6, 2007, Pages 50-56

  Lafzi, Ardeshir ^a   Farahani, Ramin Mostofi Zadeh ^a   Shoja, Mohammad Ali Mohajjel ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hyperplasia; Phenobarbital; Pseudoepitheliomatous hyperplasia

Indexed keywords

EID: 34548453103     PISSN: None     EISSN: 15263711     Source Type: Journal    
DOI: 10.5005/jcdp-8-6-50     Document Type: Article

References (10)

1. Takada K, Sugiyama H, Umezawa K, Mega J, Hirasawa M. The subgingival microflora in phenytoin-induced gingival hyperplasia. J Periodontal Res. 2003;38(5):477-81.
2. Sinha S, Kamath V, Arunodaya GR, Taly AB. Phenobarbitone induced gingival hyperplasia. J Neurol Neurosurg Psychiatry. 2002;73(5):601.
3. Kuru L, Yilmaz S, Kuru B, Kose KN, Noyan U. Expression of growth factors in the gingival crevice fluid of patients with phenytoin-induced gingival enlargement. Arch Oral Biol. 2004;49(11):945-50.
4. Hassell T, Gilbert G. Phenytoin sensitivity of fibroblasts as the basis for susceptibility to gingival enlargement. Am J Pathol 1983;112:218-223.
5. Brown RS, Beaver WT, Bottomley WK. On the mechanism of drug-induced gingival hyperplasia. J Oral Pathol Med 1991;20:201-209.
6. Bardana EJ Jr, Gabourel JD, Davies GH, Craig S. Effects of phenytoin on man's immunity. Evaluation of changes in serum immunoglobulins, complement, and antinuclear antibody. Am J Med 1983;74:289-296.
7. Drew H, Vogel R, Molofsky W, Baker H, Frank O. Effect of folate on phenytoin hyperplasia. J Clin Periodontol. 1987;14:350-356.
8. Resat H, Ewald JA, Dixon DA, Wiley HS. An integrated model of epidermal growth factor receptor trafficking and signal transduction. Biophys J. 2003;85(2):730-43.
9. Jirtle RL, Meyer SA. Liver tumor promotion: effect of phenobarbital on EGF and protein kinase C signal transduction and transforming growth factor-beta 1 expression. Dig Dis Sci. 1991;36(5):659-68.
10. Barkan GA, Paulino AF. Are epidermal growth factor and transforming growth factor responsible for pseudoepitheliomatous hyperplasia associated with granular cell tumors? Ann Diagn Pathol. 2003;7(2):73-7.